Kangtai Biotech (300601.SZ) released results for the first three quarters, with net profit of 95.3511 million yuan to mother, an increase of 93.97% over the previous year

According to the Zhitong Finance App, Kangtai Biotech (300601.SZ) released its report for the third quarter of 2026. In the first three quarters, the company achieved revenue of 1,841 billion yuan, a year-on-year decrease of 10.79%. Net profit attributable to shareholders of listed companies was 95.3511 million yuan, an increase of 93.97% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 589.19 million yuan, an increase of 111.34% over the previous year.